Canadian Diabetes Association operating as Diabetes Canada
| Specific Topics of Lobbying Communications | Intended Outcomes | Associated Subject Matters |
|---|---|---|
|
As mandated by the Public Health Agency of Canada (PHAC) Diabetes Canada has been contracted to convene senior public servants and other stakeholders over three years beginning 2023 to advance the adoption of the Framework for Diabetes in Canada that was tabled on October 5, 2022 in the House of Commons.
|
Development, establishment, amendment or termination of any program, policy, directive or guideline of the government of British Columbia or a Provincial entity
|
Health
|
|
Diabetes Canada is recommending the government of British Columbia make changes to the provincial reporting requirements of the inhouse lobbyists of health chartities to the BC Lobbyist Registry.
|
Development, establishment, amendment or termination of any program, policy, directive or guideline of the government of British Columbia or a Provincial entity, Development or enactment of any regulation, including the enactment of a regulation for the purposes of amending or repealing a regulation, Introduction, amendment, passage or defeat of any Bill or resolution in or before the Legislative Assembly
|
Justice and Law Enforcement
|
|
Diabetes Canada recommends that students living with diabetes be exempt from a provincial policy that restricts cellphone access in schools.
|
Development, establishment, amendment or termination of any program, policy, directive or guideline of the government of British Columbia or a Provincial entity
|
Education, Health
|
|
Diabetes Canada recommends the government of British Columbia enhance access to diabetes medications, devices and supplies, and supports for British Columbians living with diabetes.
|
Development, establishment, amendment or termination of any program, policy, directive or guideline of the government of British Columbia or a Provincial entity, Development or enactment of any regulation, including the enactment of a regulation for the purposes of amending or repealing a regulation, Development of any legislative proposal by the government of British Columbia, a Provincial entity or a member of the Legislative Assembly, Introduction, amendment, passage or defeat of any Bill or resolution in or before the Legislative Assembly
|
Finances and Budgets, Health
|
|
Diabetes Canada recommends the government of British Columbia expand patient choice of medications, devices and supplies because managing diabetes cannot be managed with a one-size-fits-all approach.
|
Development, establishment, amendment or termination of any program, policy, directive or guideline of the government of British Columbia or a Provincial entity
|
Finances and Budgets, Health
|
|
Diabetes Canada recommends the government of British Columbia implement a comprehensive provincial diabetes strategy that aligns with the Framework for Diabetes in Canada that was tabled on October 5, 2022 in the House of Commons.
|
Development, establishment, amendment or termination of any program, policy, directive or guideline of the government of British Columbia or a Provincial entity, Introduction, amendment, passage or defeat of any Bill or resolution in or before the Legislative Assembly, Development or enactment of any regulation, including the enactment of a regulation for the purposes of amending or repealing a regulation, Development of any legislative proposal by the government of British Columbia, a Provincial entity or a member of the Legislative Assembly
|
Finances and Budgets, Health
|
|
Diabetes Canada recommends the government of British Columbia reduce the administrative and other barriers to access so British Columbians living with diabetes can readily access the medication, devices and supplies they need to manage their diabetes.
|
Development, establishment, amendment or termination of any program, policy, directive or guideline of the government of British Columbia or a Provincial entity
|
Finances and Budgets, Health
|